Inpatients
Conditions
Interventions
This is a single-arm study, with open-label (no masking) and non-random allocation (convenience recruitment). It refers to a type II hybrid quasi-experimental implementation study with a pragmatic, si
Sponsors
Universidade de Brasília
Secretaria de Estado de Saúde do Distrito Federal
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hospitals within the network of the Federal District State Health Secretariat (SES/DF) that voluntarily joined the implementation project through formal registration and institutional consent were included. The selection of hospitals was carried out by the Implementation Team (IT), based on criteria of acceptability, appropriateness, and feasibility collected using adapted instruments—the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM)—which were completed by the hospitals at the time of registration. At the individual level, pharmacists affiliated with the participating hospitals were included, who were working in clinical pharmacy services during the study period, were 18 years of age or older, and agreed to participate by signing the Informed Consent Form (ICF)
Exclusion criteria
Exclusion criteria: Clinical Pharmacy Units (CPUs) will be excluded from the study if they fail to attend periodic meetings and mentoring sessions without justification, if less than 80% of their staff participates in the educational program offered, or if they repeatedly fail to meet the deadlines for submitting the requested data. Pharmacists who are on leave from their duties during the data collection period or who have left the CPU during the study will also be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study aims to evaluate the outcomes of implementing comprehensive, longitudinal pharmaceutical care related to a bundle of clinical services provided by pharmacists at hospital admission, discharge, and post-discharge, using quantitative (e.g., rate of patients admitted by a pharmacist, rate of patients receiving post-discharge follow-up) and qualitative (examples: semi-structured interviews, checklists, questionnaires) methods, depending on the outcome. Adoption, acceptability, feasibility, fidelity, appropriateness, and penetration will be analyzed, selected from Proctor’s taxonomy according to their relevance to the present study;The study aims to evaluate the outcomes of a comprehensive, longitudinal pharmaceutical care intervention, related to a bundle of clinical services provided by pharmacists at hospital admission, discharge, and post-discharge, using quantitative methods (e.g.,analysis of records in electronic patient records and health information systems), depending on the outcome. Readmission within 90 days and length of stay will be analyzed | — |
Secondary
| Measure | Time frame |
|---|---|
| The study aims to evaluate the outcomes of a comprehensive, longitudinal pharmaceutical care intervention related to a bundle of clinical services provided by pharmacists at hospital admission, discharge, and post-discharge, using qualitative methods (e.g., semi-structured interviews) and quantitative methods (e.g., analysis of records in electronic patient records and health information systems), depending on the outcome. Analysis will include 90-day mortality, mortality rate, patient satisfaction, professional satisfaction, and presumed cost savings calculated from the pharmaceutical intervention | — |
Countries
BR
Contacts
Public ContactRodrigo;Dafny Lima;de Matos
Universidade de Brasília;Universidade de Brasília
Outcome results
None listed